Treatment Preference for Alzheimer’s Disease: A Multicriteria Decision Analysis with Caregivers, Neurologists, and Payors

INTRODUCTION: Alzheimer’s disease (AD) is a chronic neurodegenerative disorder associated with a high burden of illness. New therapies under development include agents that target amyloid-beta (Aβ), a key component in AD pathogenesis. Understanding the decision-making process for new AD drugs would...

Descripción completa

Detalles Bibliográficos
Autores principales: Dranitsaris, George, Zhang, Quanwu, Quill, Alex, Mu, Lin, Weyrer, Christopher, Dysdale, Erik, Neumann, Peter, Tahami Monfared, Amir Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837350/
https://www.ncbi.nlm.nih.gov/pubmed/36422822
http://dx.doi.org/10.1007/s40120-022-00423-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837350/
https://www.ncbi.nlm.nih.gov/pubmed/36422822
http://dx.doi.org/10.1007/s40120-022-00423-y

Ejemplares similares